A review on the modern drug discovery process
Keywords:
drug, ADME, absorption, distribution, metabolism and excretion; DMPK, drug metabolism pharmacokinetics, DMSO, dimethyl sulphoxide, GPCRs, G-protein-coupled receptors, HTS, immoderate throughput screening, mAbs, human monoclonal antibodies, PD, pharmacodynamic, PK, pharmacokinetic, SAR, shape–interest datingAbstract
Drug discovery manner is a crucial issue inside the pharmaceutical industry seeing that it's far a completely value-powerful and time ingesting technique to provide new drug potentials and enlarge the scope of illnesses incurred. Drug purpose identity, being the first phase in drug discovery is becoming a very time-ingesting procedure. in many instances, such produces inefficient effects because of the failure of conventional techniques like in vivo and in vitro to analyze massive scale information. developing a brand-new drug from particular idea to the launch of a completed product is a complex manner that would take 12–15 years and fee in excess of $1 billion. The concept for a goal can come from an expansion of resources which include educational and scientific studies and from the industrial sector. it is able to take a few years to accumulate a body of helping evidence earlier than choosing a goal for a f drug discovery programme. once a target has been selected, the pharmaceutical agency and more lately a few instructional centres have streamlined some of early strategies to select out molecules which own appropriate traits o make ideal drugs.
Downloads
References
Abell AN, Rivera-Perez JA, Cuevas BD, Uhlik MT, Sather S, Johnson NL et al. (2005).
Ablation of MEKK4 kinase activity causes neurulation and skeletal patterning defects in the mouse embryo.
Mol Cell Biol 25: 8948–8959. Bertram L, Tanzi RE (2008). Thirty years of Alzheimer’s disease genetics: the implications of systematic meta-analyses.
Nat Rev Neurosci 9: 768–778. Boppana K, Dubey PK, Jagarlapudi SARP, Vadivelan S, Rambabu G (2009).
Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
Eur J Med Chem 44: 3584–3590. Castanotto D, Rossi JJ (2009).
The promises and pitfalls of RNA-interference-based therapeutics.
Nature 457: 426–433. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P et al. (2005). Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain.
Pain 114: 386–396. Cox JJ, Reimann F, Nicholas AK (2006). An SCN9A channelopathy causes congenital inability to experience pain. Nature 444: 894–898.
Current approaches in drug discovery.” Pharma Times, 38(8). August. Yongliang Y, Adelstein SJ, Amin IK (2009). Target discovery from data mining approaches. 20 January. Taylor, Francis (2006).
In silico Technologies in Drug Target Identification and Validation.
Taylor and Francis Group, LLC. Xiaofeng L, Sisheng O, Biao Y, Yabo L, Kai H, Jiayu G, Siyuan Z, Zhihua L, Honglin L, Hualiang J (2010). “PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach” Nucleic Acids Res., 38: W609-W614.
Pankaj, “Cyclodextrin modified block polymer for oral chemotherapy,” J. Pharm. Res. Int., pp. 21–29, 2021.
Kustina, K.T., Dewi, G.A.A.O., Prena, G.D., Suryasa, W. (2019). Branchless banking, third-party funds, and profitability evidence reference to banking sector in indonesia. Journal of Advanced Research in Dynamical and Control Systems, 11(2), 290-299.
Suryasa, I.W., Sudipa, I.N., Puspani, I.A.M., Netra, I.M. (2019). Translation procedure of happy emotion of english into indonesian in kṛṣṇa text. Journal of Language Teaching and Research, 10(4), 738–746
Rusli, D., Ariani, D. N., Nurmina, N., & Rinaldi, R. (2021). Influence of exposure to children’s movies on television on theory-of- mind acquisition in preschoolers. International Journal of Health & Medical Sciences, 4(1), 44-49. https://doi.org/10.31295/ijhms.v4n1.650
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
